Orphazyme

0 followers

‌

Danish biopharma company, listed on Nasdaq Copenhagen, with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Anders Vadsholt

CEO & CFO

Anders Fink V.

Chief Executive Officer

Teams

Board of Directors

0 members

CEO and Executive Team

1 members

Leadership Team

1 members

Similar companies

Dyno Therapeutics

4 followers

BioMarin Pharmaceutical

21 followers

Adaptive Biotechnologies

11 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Discover companies